Adynxx Inc ADYX
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.04
- 52-Week Range
- $0.00–0.04
- Bid/Ask
- $0.00 / $0.60
- Shares Outstanding
- 5.81M
- Market Cap
- $580.79
- Volume/Avg
- 885 / 864
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Adynxx Inc is a United States-based clinical-stage biopharmaceutical company. It is focused on the development of a new class of therapeutics called transcription factor decoys and bringing to the market novel, disease-modifying products to address unmet needs in the treatment of pain and inflammation. Its pipeline includes brivoligide, a Phase 2 drug candidate intended to address postoperative pain, and AYX2, a pre-clinical candidate intended to treat chronic syndromes of pain, including both inflammatory and neuropathic pain.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Small Value
- Total Number of Employees
- 6
- Website
- http://www.adynxx.com
Valuation
Metric | ADYX |
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
Metric | ADYX |
|---|---|
Quick Ratio | 0.02 |
Current Ratio | 0.18 |
Interest Coverage | −2.61 |
Quick Ratio
ADYX
Profitability
Metric | ADYX |
|---|---|
Return on Assets (Normalized) | −129.94% |
Return on Equity (Normalized) | −1,026.61% |
Return on Invested Capital (Normalized) | −148.29% |
Return on Assets
ADYX
Biotechnology Industry Comparables
1-Day Chart | Name | Price | Morningstar Rating for Stocks | Capital Allocation | Economic Moat | Market Cap |
|---|---|---|---|---|---|---|
| Vertex Pharmaceuticals Inc VRTX | LOCK|#s#%pMC | LOCK|?xW!F | $131B | |||
| Regeneron Pharmaceuticals Inc REGN | LOCK|!dk>!kf | LOCK|B^YP | $95B | |||
| Moderna Inc MRNA | LOCK|^dRkK%& | LOCK|X^? | $79B | |||
| argenx SE ADR ARGX | LOCK|nssSx! | LOCK|!P& | $59B | |||
| BeOne Medicines Ltd ADR ONC | LOCK|#$@z!$f | LOCK|G!> | $45B | |||
| Royalty Pharma PLC Class A RPRX | LOCK|>dtgrPp | LOCK|ssP^ | $30B | |||
| Incyte Corp INCY | LOCK|^?bJ!& | LOCK|Bqd | $23B | |||
| BioNTech SE ADR BNTX | LOCK|zJ#<S! | LOCK|v! | $20B | |||
| Alnylam Pharmaceuticals Inc ALNY | LOCK|!RW#^TB | LOCK|&B!^q | $19B | |||
| BridgeBio Pharma Inc BBIO | LOCK|f@JZbc | LOCK|Tb | $15B |